Developer docs
API playgroundTry for free, no card

Search company profiles

pharmacure pharmaceutical

Full company profile

uuid0053mho

Namestring
pharmacure pharmaceutical
Legal namestring
PharmaCureOnline
Company typeenum
Private
Founded yearint
1999
Descriptiontext

PharmaCure Pharmaceutical Industries is a privately-held Egyptian pharmaceutical manufacturer founded in 1999, operating from a manufacturing facility in the 4th Industrial Zone of El Sadat City and a separate marketing and distribution center in Obour City. The company produces a multi-category generic pharmaceutical portfolio in solid dosage (tablets, coated tablets, hard gelatin capsules), liquid dosage (syrups, suspensions), purified water, and veterinary powder forms, spanning diabetes (Pharmavildamin), hypertension (Alphdopa), benign prostatic hyperplasia (Congdosin), allergies (Pharmabilast), bacterial infections (Azropharma, Oxazolide, Primoxizar), gastrointestinal disorders (Razopump, Rebamucaulc), cold symptoms (Rhinocalm), and lactation support (Herbana).

Production is conducted under cGMP and WHO compliance frameworks, with self-contained and isolated human and veterinary production lines supported by HVAC, water treatment, boiler, and compressed air utility systems. The facility holds ISO 9001:2015 (quality management), ISO 14001:2015 (environmental management), and ISO 45001:2018 (occupational health and safety) certifications, and is organized across dedicated Engineering, Quality Assurance, Quality Control, Warehouse, and Production departments. Headcount is reported at 11-50 employees.

PharmaCure operates a B2B distribution-led model, selling products through Egyptian pharmacy networks and healthcare providers, with revenue generated through one-time unit sales rather than licensing or subscription arrangements. The company markets through its website (pharmacureonline.com), its Obour City in-house marketing team, and direct outreach, and operates a Pharmacovigilance department for post-market surveillance. No revenue, funding, or external institutional ownership data is disclosed; the company appears to be founder/owner-operated with no parent or holding structure indicated.

Short descriptiontext

PharmaCure Pharmaceutical Industries is a privately-held Egyptian generic pharmaceutical manufacturer founded in 1999, producing cGMP- and WHO-compliant tablets, capsules, syrups, and suspensions across multiple therapeutic categories for distribution through Egyptian pharmacy networks.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
51–100
akta.pro rankint
HeadquartersEl Zahraa, Cairo, Egypt
HQ citystring
El Zahraa, Cairo
HQ countrystring
Egypt
HQ regionstring
Africa
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
pharmaceutical manufacturing, generic medicines, human pharmaceuticals, dosage forms, cGMP compliance
Industry1 code
PRIMARYHLAMAEAM
Generic & Private-Label Veterinary Pharmaceuticals
Healthcare & Life Sciences/Veterinary & Animal Health/Veterinary Pharmaceuticals & Biologics
NAICS code1 code
  • Pharmaceutical Preparation Manufacturing325412
SIC code1 code
  • Pharmaceutical Preparations2834
Product category
Generic Pharmaceuticals Manufacturing
Social media profiles1 record
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Pharmaceutical Product Sales
TypeOne Time License
Description

Manufacture and sale of pharmaceutical products including tablets, capsules, syrups, and suspensions to healthcare providers and patients through distribution channels.

pharmacureonline.com
Marketing channels2 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Supply Chain, Operations, Personnel, Marketing or Sales, Technology or R&D, Infrastructure
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 12 records shown
1Congdosin
Description

Silodosin capsules for treatment of benign prostatic hyperplasia (BPH)

pharmacureonline.com
+11 more records
Core offering1 text field

PharmaCure Pharmaceutical Industries manufactures a broad portfolio of branded generic human and veterinary pharmaceutical products in multiple dosage forms, including tablets, coated tablets, hard gelatin capsules, syrups, suspensions, and powder formulations. Production takes place at a cGMP- and WHO-compliant manufacturing facility in El Sadat City, Egypt, with products distributed through pharmacy networks and healthcare providers in Egypt.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 2 values shown
  • 120% increase in turnover every six months organically
+1 more record
Product overview1 text field

PharmaCure Pharmaceutical Industries is an established Egyptian pharmaceutical company founded in 1999, operating as a modern pharmaceutical manufacturing facility with cGMP and WHO-compliant production. The company produces a diverse portfolio of human and veterinary pharmaceutical products across multiple dosage forms. Human products include solid dosage forms (tablets, coated tablets, hard gelatin capsules) and liquid dosage forms (syrups and suspensions). The product portfolio covers therapeutic areas including diabetes management (Pharmavildamin 50/850 and 50/1000 Tablets), allergy treatment (Pharmabilast Tablets and Syrup), cold and flu relief (Rhinocalm Tablets and Syrup), hypertension (Alphdopa Tablets), benign prostatic hyperplasia (Congdosin 4 mg and 8 mg), herbal medicine for lactation (Herbana Capsules), antibiotics (Oxazolide Tablets and Suspension, Azropharma 500 mg Tablets, Primoxizar Tablets), gastrointestinal disorders (Razopump 20 mg and 40 mg Capsules, Rebamucaulc Tablets), and general wellness supplements (Unovit Syrup). Production is supported by dedicated Engineering, Quality Assurance, Quality Control, Warehouse, and Production departments.

Product and service13 records
1Pharmavildamin Tablets (50/850 and 50/1000)
CategoryAntidiabetic medications
Description

Combination tablets containing 50 mg vildagliptin with either 850 mg or 1000 mg metformin hydrochloride, used as adjunct to diet and exercise for glycemic control in adults with type 2 diabetes mellitus.

2Pharmabilast Tablets and Syrup
CategoryAntiallergic medications
Description

Bilastine 20 mg tablets and 2.5 mg/ml oral solution for symptomatic treatment of allergic rhino-conjunctivitis (seasonal and perennial) and urticaria.

3Rhinocalm Tablets and Syrup
CategoryCold and flu medications
Description

Combination of Paracetamol, Chlorpheniramine maleate, and Pseudoephedrine hydrochloride in tablet and syrup forms for relief of common cold symptoms.

4Alphdopa Tablets
CategoryAntihypertensive medications
Description

Tablet containing Methyldopa sesquihydrate 281.93 mg, used for the treatment of hypertension.

5Congdosin Capsules (4 mg and 8 mg)
CategoryUrological medications
Description

Hard gelatin capsules containing 4 mg or 8 mg Silodosin, used for treatment of signs and symptoms of benign prostatic hyperplasia (BPH).

6Herbana Capsules
CategoryHerbal supplements
Description

Herbal medicine in hard gelatin capsules containing Fenugreek seed powder, Fennel fruit powder, Dill fruit powder, and Caraway fruit powder, used as a lactagogue to improve lactation.

7Oxazolide Tablets and Suspension
CategoryAntibiotic medications
Description

Linezolid 600 mg tablets and 100 mg/5 ml oral suspension for treatment of susceptible strains of microorganisms in pneumonia and skin and skin structure infections.

8Azropharma 500 mg Tablets
CategoryAntibiotic medications
Description

Film-coated tablets containing 500 mg Azithromycin, indicated for acute bacterial sinusitis, acute bacterial otitis media, pharyngitis, tonsillitis, acute exacerbation of chronic bronchitis, community acquired pneumonia, skin and soft tissue infections, and uncomplicated Chlamydia trachomatis urethritis and cervicitis.

9Primoxizar Tablets
CategoryAntibiotic medications
Description

Film-coated tablet containing Moxifloxacin HCl 400 mg, used for treatment of bacterial infections.

10Razopump Capsules (20 mg and 40 mg)
CategoryGastrointestinal medications
Description

Delayed release hard gelatin capsules containing 20 mg or 40 mg Esomeprazole, used for healing of erosive esophagitis, symptomatic GERD, and Helicobacter pylori eradication to reduce risk of duodenal ulcer recurrence.

11Rebamucaulc Tablets
CategoryGastrointestinal medications
Description

Film-coated tablet containing 100 mg Rebamipide, used for gastric ulcer and improvement of gastric mucosal lesions including erosion, bleeding, redness, and edema in acute gastritis and acute exacerbation of chronic gastritis.

12Unovit Syrup
CategoryWellness supplements
Description

Syrup containing 100 mg lyophilized royal jelly per 5 ml, used for support of body functions.

13Veterinary Powder Dosage Forms
CategoryVeterinary pharmaceuticals
Description

Veterinary solid dosage form products in powder formulation, produced under cGMP-compliant manufacturing lines.

Scale indicator5 records

Each record includes

Type, Value, Description, Source

Partnership1 partner
Strategic tierMinorTypeOthers
Description

The company mentions having partners in the pharmaceutical industry but specific partner names are not listed on the website.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight4 records

Each record includes

Type, Description

Peers8 records
TypeBroad incumbent
Description

Indian-headquartered global generic pharmaceutical manufacturer with strong presence in Africa and other emerging markets. Comparable to PharmaCure on generic product type and therapeutic breadth, particularly relevant as a benchmark for Africa-oriented generic expansion strategies.

TypeDirect peer
Description

Egypt's largest pharmaceutical manufacturer, producing generic human medicines across a wide therapeutic portfolio. Highly comparable to PharmaCure on product type, target market, and manufacturing model, with substantial scale advantage.

TypeDirect peer
Description

Long-established Egyptian generic pharmaceutical manufacturer producing a broad portfolio of human generics and some veterinary products. Closely comparable to PharmaCure on product type, Egyptian market focus, and multi-dosage form manufacturing.

4Julphar (Gulf Pharmaceutical Industries)
TypeRegional player
Description

UAE-based generic pharmaceutical manufacturer producing tablets, capsules, syrups, and injectables for MENA markets. Comparable to PharmaCure on dosage form capabilities and regional MENA positioning, serving as a regional rather than direct Egyptian competitor.

TypeDirect peer
Description

One of Egypt's largest domestic pharmaceutical manufacturers producing generics across multiple therapeutic categories and dosage forms. Directly comparable to PharmaCure in product type (generic human pharmaceuticals), therapeutic breadth, and Egyptian domestic market focus, though at materially larger scale.

TypeRegional player
Description

Saudi Arabia's largest pharmaceutical manufacturer producing generics across multiple therapeutic areas. Comparable to PharmaCure on generic manufacturing model and MENA regional positioning, though focused primarily on the Saudi market.

TypeBroad incumbent
Description

Jordan-headquartered multinational generic and specialty pharmaceutical company with a strong MENA manufacturing and commercial footprint. Comparable to PharmaCure as a MENA-based generic manufacturer with broad therapeutic coverage, though operating at substantially greater scale and geographic reach.

TypeDirect peer
Description

Egypt-based pharmaceutical manufacturer with operations in both human generics and biopharmaceuticals. Comparable to PharmaCure on Egyptian manufacturing footprint and broad generic portfolio, with additional exposure to biologics.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment1 record

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature3 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
No data
Compliance5 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

pharmacure pharmaceutical

Generic Pharmaceuticals Manufacturingpharmacureonline.com

PharmaCure Pharmaceutical Industries is a privately-held Egyptian generic pharmaceutical manufacturer founded in 1999, producing cGMP- and WHO-compliant tablets, capsules, syrups, and suspensions across multiple therapeutic categories for distribution through Egyptian pharmacy networks.

What pharmacure pharmaceutical does

PharmaCure Pharmaceutical Industries is a privately-held Egyptian pharmaceutical manufacturer founded in 1999, operating from a manufacturing facility in the 4th Industrial Zone of El Sadat City and a separate marketing and distribution center in Obour City. The company produces a multi-category generic pharmaceutical portfolio in solid dosage (tablets, coated tablets, hard gelatin capsules), liquid dosage (syrups, suspensions), purified water, and veterinary powder forms, spanning diabetes (Pharmavildamin), hypertension (Alphdopa), benign prostatic hyperplasia (Congdosin), allergies (Pharmabilast), bacterial infections (Azropharma, Oxazolide, Primoxizar), gastrointestinal disorders (Razopump, Rebamucaulc), cold symptoms (Rhinocalm), and lactation support (Herbana).

Production is conducted under cGMP and WHO compliance frameworks, with self-contained and isolated human and veterinary production lines supported by HVAC, water treatment, boiler, and compressed air utility systems. The facility holds ISO 9001:2015 (quality management), ISO 14001:2015 (environmental management), and ISO 45001:2018 (occupational health and safety) certifications, and is organized across dedicated Engineering, Quality Assurance, Quality Control, Warehouse, and Production departments. Headcount is reported at 11-50 employees.

PharmaCure operates a B2B distribution-led model, selling products through Egyptian pharmacy networks and healthcare providers, with revenue generated through one-time unit sales rather than licensing or subscription arrangements. The company markets through its website (pharmacureonline.com), its Obour City in-house marketing team, and direct outreach, and operates a Pharmacovigilance department for post-market surveillance. No revenue, funding, or external institutional ownership data is disclosed; the company appears to be founder/owner-operated with no parent or holding structure indicated.

pharmacure pharmaceutical firmographics

Firmographics
Name
pharmacure pharmaceutical
Legal name
PharmaCureOnline
Website
https://pharmacureonline.com
Company type
Private
Founded year
1999
Operating status
Operating
Headcount range
51–100 employees
Short description
PharmaCure Pharmaceutical Industries is a privately-held Egyptian generic pharmaceutical manufacturer founded in 1999, producing cGMP- and WHO-compliant tablets, capsules, syrups, and suspensions across multiple therapeutic categories for distribution through Egyptian pharmacy networks.
Ownership category
akta.pro rank

pharmacure pharmaceutical industry classification

Industry
Product category
Generic Pharmaceuticals Manufacturing
NAICS
Pharmaceutical Preparation Manufacturing (325412)
SIC
Pharmaceutical Preparations (2834)
akta.pro industry
PRIMARYHLAMAEAM
Generic & Private-Label Veterinary Pharmaceuticals
Healthcare & Life Sciences/Veterinary & Animal Health/Veterinary Pharmaceuticals & Biologics

Keywords

  • Pharmaceutical manufacturing
  • Generic medicines
  • Human pharmaceuticals
  • Dosage forms
  • CGMP compliance

Where pharmacure pharmaceutical is headquartered

Location

Headquarters

HQ city
El Zahraa, Cairo
HQ country
Egypt
HQ region
Africa

Offices2 records

Markets served

pharmacure pharmaceutical business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Supply Chain, Operations, Personnel, Marketing or Sales, Technology or R&D, Infrastructure

Revenue model

  1. Pharmaceutical Product Sales: Manufacture and sale of pharmaceutical products including tablets, capsules, syrups, and suspensions to healthcare providers and patients through distribution channels.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels2 records

pharmacure pharmaceutical product offering

Product offering

Core offering

PharmaCure Pharmaceutical Industries manufactures a broad portfolio of branded generic human and veterinary pharmaceutical products in multiple dosage forms, including tablets, coated tablets, hard gelatin capsules, syrups, suspensions, and powder formulations. Production takes place at a cGMP- and WHO-compliant manufacturing facility in El Sadat City, Egypt, with products distributed through pharmacy networks and healthcare providers in Egypt.

Product overview

PharmaCure Pharmaceutical Industries is an established Egyptian pharmaceutical company founded in 1999, operating as a modern pharmaceutical manufacturing facility with cGMP and WHO-compliant production. The company produces a diverse portfolio of human and veterinary pharmaceutical products across multiple dosage forms. Human products include solid dosage forms (tablets, coated tablets, hard gelatin capsules) and liquid dosage forms (syrups and suspensions). The product portfolio covers therapeutic areas including diabetes management (Pharmavildamin 50/850 and 50/1000 Tablets), allergy treatment (Pharmabilast Tablets and Syrup), cold and flu relief (Rhinocalm Tablets and Syrup), hypertension (Alphdopa Tablets), benign prostatic hyperplasia (Congdosin 4 mg and 8 mg), herbal medicine for lactation (Herbana Capsules), antibiotics (Oxazolide Tablets and Suspension, Azropharma 500 mg Tablets, Primoxizar Tablets), gastrointestinal disorders (Razopump 20 mg and 40 mg Capsules, Rebamucaulc Tablets), and general wellness supplements (Unovit Syrup). Production is supported by dedicated Engineering, Quality Assurance, Quality Control, Warehouse, and Production departments.

Differentiator

Problem solved

Functional benefit

Brands

  • Congdosin: Silodosin capsules for treatment of benign prostatic hyperplasia (BPH)
  • Pharmavildamin
  • Herbana
  • Razopump
  • Azropharma
  • Rebamucaulc
  • Oxazolide
  • Pharmabilast
  • Unovit
  • Rhinocalm
  • Alphdopa
  • Primoxizar

Products and services

  • Pharmavildamin Tablets (50/850 and 50/1000) Combination tablets containing 50 mg vildagliptin with either 850 mg or 1000 mg metformin hydrochloride, used as adjunct to diet and exercise for glycemic control in adults with type 2 diabetes mellitus.
  • Pharmabilast Tablets and Syrup Bilastine 20 mg tablets and 2.5 mg/ml oral solution for symptomatic treatment of allergic rhino-conjunctivitis (seasonal and perennial) and urticaria.
  • Rhinocalm Tablets and Syrup Combination of Paracetamol, Chlorpheniramine maleate, and Pseudoephedrine hydrochloride in tablet and syrup forms for relief of common cold symptoms.
  • Alphdopa Tablets Tablet containing Methyldopa sesquihydrate 281.93 mg, used for the treatment of hypertension.
  • Congdosin Capsules (4 mg and 8 mg) Hard gelatin capsules containing 4 mg or 8 mg Silodosin, used for treatment of signs and symptoms of benign prostatic hyperplasia (BPH).
  • Herbana Capsules Herbal medicine in hard gelatin capsules containing Fenugreek seed powder, Fennel fruit powder, Dill fruit powder, and Caraway fruit powder, used as a lactagogue to improve lactation.
  • Oxazolide Tablets and Suspension Linezolid 600 mg tablets and 100 mg/5 ml oral suspension for treatment of susceptible strains of microorganisms in pneumonia and skin and skin structure infections.
  • Azropharma 500 mg Tablets Film-coated tablets containing 500 mg Azithromycin, indicated for acute bacterial sinusitis, acute bacterial otitis media, pharyngitis, tonsillitis, acute exacerbation of chronic bronchitis, community acquired pneumonia, skin and soft tissue infections, and uncomplicated Chlamydia trachomatis urethritis and cervicitis.
  • Primoxizar Tablets Film-coated tablet containing Moxifloxacin HCl 400 mg, used for treatment of bacterial infections.
  • Razopump Capsules (20 mg and 40 mg) Delayed release hard gelatin capsules containing 20 mg or 40 mg Esomeprazole, used for healing of erosive esophagitis, symptomatic GERD, and Helicobacter pylori eradication to reduce risk of duodenal ulcer recurrence.
  • Rebamucaulc Tablets Film-coated tablet containing 100 mg Rebamipide, used for gastric ulcer and improvement of gastric mucosal lesions including erosion, bleeding, redness, and edema in acute gastritis and acute exacerbation of chronic gastritis.
  • Unovit Syrup Syrup containing 100 mg lyophilized royal jelly per 5 ml, used for support of body functions.
  • Veterinary Powder Dosage Forms Veterinary solid dosage form products in powder formulation, produced under cGMP-compliant manufacturing lines.

Quantifiable outcome

  • 120% increase in turnover every six months organically
  • +1 more outcomes

Companies that use pharmacure pharmaceutical

Customer profile

Segments1 record

Ideal customer profiles1 record

pharmacure pharmaceutical technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature3 records

pharmacure pharmaceutical partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • Pharmaceutical Industry PartnersminorOthersThe company mentions having partners in the pharmaceutical industry but specific partner names are not listed on the website.

Scale indicators5 records

Recent moves6 records

Expansion highlights4 records

pharmacure pharmaceutical competitors and assessment

Company assessment

Broad incumbents

  • Cipla: Indian-headquartered global generic pharmaceutical manufacturer with strong presence in Africa and other emerging markets. Comparable to PharmaCure on generic product type and therapeutic breadth, particularly relevant as a benchmark for Africa-oriented generic expansion strategies.
  • Hikma Pharmaceuticals: Jordan-headquartered multinational generic and specialty pharmaceutical company with a strong MENA manufacturing and commercial footprint. Comparable to PharmaCure as a MENA-based generic manufacturer with broad therapeutic coverage, though operating at substantially greater scale and geographic reach.

Direct peers

  • Pharco Pharmaceuticals: Egypt's largest pharmaceutical manufacturer, producing generic human medicines across a wide therapeutic portfolio. Highly comparable to PharmaCure on product type, target market, and manufacturing model, with substantial scale advantage.
  • Egyptian International Pharmaceutical Industries Company (EIPICO): Long-established Egyptian generic pharmaceutical manufacturer producing a broad portfolio of human generics and some veterinary products. Closely comparable to PharmaCure on product type, Egyptian market focus, and multi-dosage form manufacturing.
  • EVA Pharma: One of Egypt's largest domestic pharmaceutical manufacturers producing generics across multiple therapeutic categories and dosage forms. Directly comparable to PharmaCure in product type (generic human pharmaceuticals), therapeutic breadth, and Egyptian domestic market focus, though at materially larger scale.
  • Minapharm Pharmaceuticals: Egypt-based pharmaceutical manufacturer with operations in both human generics and biopharmaceuticals. Comparable to PharmaCure on Egyptian manufacturing footprint and broad generic portfolio, with additional exposure to biologics.

Regional players

  • Julphar (Gulf Pharmaceutical Industries): UAE-based generic pharmaceutical manufacturer producing tablets, capsules, syrups, and injectables for MENA markets. Comparable to PharmaCure on dosage form capabilities and regional MENA positioning, serving as a regional rather than direct Egyptian competitor.
  • SPIMACO Addwaeih: Saudi Arabia's largest pharmaceutical manufacturer producing generics across multiple therapeutic areas. Comparable to PharmaCure on generic manufacturing model and MENA regional positioning, though focused primarily on the Saudi market.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

pharmacure pharmaceutical social profiles

Digital presence

pharmacure pharmaceutical compliance and trust

Trust signal

Compliance5 records

pharmacure pharmaceutical financial estimates

Financial estimate

Revenue estimate

Valuation estimate

pharmacure pharmaceutical leadership team

Management profile

Number of profiles

pharmacure pharmaceutical funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

pharmacure pharmaceutical M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about pharmacure pharmaceutical

What does pharmacure pharmaceutical do?

PharmaCure Pharmaceutical Industries manufactures a broad portfolio of branded generic human and veterinary pharmaceutical products in multiple dosage forms, including tablets, coated tablets, hard gelatin capsules, syrups, suspensions, and powder formulations. Production takes place at a cGMP- and WHO-compliant manufacturing facility in El Sadat City, Egypt, with products distributed through pharmacy networks and healthcare providers in Egypt.

Is pharmacure pharmaceutical a public or private company?

pharmacure pharmaceutical is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was pharmacure pharmaceutical founded?

pharmacure pharmaceutical was founded in 1999. It employs 51 to 100 people.

Where is pharmacure pharmaceutical based?

pharmacure pharmaceutical is headquartered in El Zahraa, Cairo, Egypt, in the Africa region.

How does pharmacure pharmaceutical make money?

One revenue line is on record: pharmaceutical Product Sales.

Who are pharmacure pharmaceutical's main competitors?

Broad incumbents on record are Cipla and Hikma Pharmaceuticals. Direct peers are Pharco Pharmaceuticals, Egyptian International Pharmaceutical Industries Company (EIPICO), EVA Pharma and Minapharm Pharmaceuticals. Regional players are Julphar (Gulf Pharmaceutical Industries) and SPIMACO Addwaeih.

Does pharmacure pharmaceutical have an API?

No public API is recorded for pharmacure pharmaceutical.

What industry is pharmacure pharmaceutical in?

pharmacure pharmaceutical's product category is Generic Pharmaceuticals Manufacturing. Its primary akta.pro industry code is HLAMAEAM, Generic & Private-Label Veterinary Pharmaceuticals. Its NAICS code is 325412 and its SIC code is 2834.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales